Home | Articles
Published on:June 2018
Indian Journal of Pharmaceutical Education and Research, 2018; 52(3):408-415
Original Article | doi:10.5530/ijper.52.3.47

Development and Evaluation of a Novel Drug Delivery System for Albendazole

Authors and affiliation (s):

Shaikh Karimunnisa1*, Pandhe Puja2, Kale Sangita1, Bothiraja Chellampillai2

1Department of Quality Assurance Techniques, Progressive Education Society’s Modern College of Pharmacy, Yamunanagar, Nigdi, Pune, INDIA.

2Department of Pharmaceutics, Poona College of Pharmacy, Paud Road, Erandawane, Pune, INDIA.


Introduction: The main objective of the present study was to develop and evaluate long circulating pegylated niosomal formulation of albendazole (ABZ). It was hypothesized thatpegylated niosomes would increase the systemic residence time of albendazole in the treatment of echinococcosis thus obviating frequent doses of albendazole. Materials and methods: ABZ was received as a gift sample from SeQuent Scientific Limited, Mahad. Span 60 niosomes pegylated with Distearoyl-sn-glycero-3-phosphoethanolamine (DSPE-PEG procured from Sigma Aldrich) were prepared by ethanol injection method. They were evaluated for particle size, entrapment efficiency, zeta potential, in-vitro release and pharmacokinetic study. Results and discussion: The pegylated niosomes were 296.39±0.62 nm in size and spherical in nature. The nanosize of the niosomes will probably help in targeting the site of treatment of echinococcosis. Zeta potential, encapsulation efficiency and in-vitro release were 3.44 mV, 98.97% w/v and 92.93% w/v respectively. T90 of pegylated niosomes was found to be twice (1440.8 min) as that of free dug (720.2 min). Thus pegylated niosomes prolonged the release of albendazole. Hemolysis produced was less than 3%; thus niosomes proved safe for intravenous injection. Conclusion: Developed pegylated niosomes have potential in the treatment of echinococcosis and hydatid cysts. These niosomes will probably reduce the frequency of administration of albendazole.

Key words: Niosomes, Prolonged release, PEG-DSPE, Pegylation, Albendazole.



Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).


Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

User login

This question is for testing whether you are a human visitor and to prevent automated spam submissions.
1 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.


IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs